Javier
García Castro
Instituto de Salud Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Salud Carlos III (49)
2023
-
Toll-like Receptor Signaling-deficient Cells Enhance Antitumor Activity of Cell-based Immunotherapy by Increasing Tumor Homing
CANCER RESEARCH COMMUNICATIONS, Vol. 3, Núm. 3, pp. 347-360
2022
-
Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment
Frontiers in Cell and Developmental Biology, Vol. 10
-
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
Veterinary Sciences, Vol. 9, Núm. 7
2021
-
AKT and JUN are differentially activated in mesenchymal stem cells after infection with human and canine oncolytic adenoviruses
Cancer Gene Therapy, Vol. 28, Núm. 1-2, pp. 64-73
-
Cancer stem cells and clonal evolution in bone sarcomas
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside (Elsevier), pp. 371-391
-
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3
-
Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain
Veterinary Research, Vol. 52, Núm. 1
-
Rgb-marking to identify patterns of selection and neutral evolution in human osteosarcoma models
Cancers, Vol. 13, Núm. 9
-
Systemic treatment of immune-mediated keratoconjunctivitis sicca with allogeneic stem cells improves the schirmer tear test score in a canine spontaneous model of disease
Journal of Clinical Medicine, Vol. 10, Núm. 24
-
The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-β1 and focal adhesion kinase activation
Cell Adhesion and Migration, Vol. 15, Núm. 1, pp. 58-73
2020
-
Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy
Molecular Therapy - Oncolytics, Vol. 18, pp. 525-534
-
Cellular virotherapy increases tumor-infiltrating lymphocytes (Til) and decreases their pd-1+ subsets in mouse immunocompetent models
Cancers, Vol. 12, Núm. 7, pp. 1-17
-
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042
-
Immunotherapy with CAR-T cells in paediatric haematology-oncology
Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10
-
Sarcoma treatment in the era of molecular medicine
EMBO Molecular Medicine, Vol. 12, Núm. 11
-
Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications
Cancers, Vol. 12, Núm. 4
2019
-
Enhanced antitumor efficacy of oncolytic adenovirus–loaded menstrual blood–derived mesenchymal stem cells in combination with peripheral blood mononuclear cells
Molecular Cancer Therapeutics, Vol. 18, Núm. 1, pp. 127-138
-
The Netrin-4/Laminin γ1/Neogenin-1 complex mediates migration in SK-N-SH neuroblastoma cells
Cell Adhesion and Migration, Vol. 13, Núm. 1, pp. 33-40
2018
-
Allogeneic adipose-derived mesenchymal stem cells (Horse Allo 20) for the treatment of osteoarthritis-associated lameness in horses: Characterization, safety, and efficacy of intra-articular treatment
Stem Cells and Development, Vol. 27, Núm. 17, pp. 1147-1160
-
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice
Cancer Immunology, Immunotherapy, Vol. 67, Núm. 10, pp. 1589-1602